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Summary 
Intercellular adhesion molecule (ICAM)  1/CD54 plays an important role in T  cell-dependent 
B  cell activation and for function of B lymphocytes as antigen-presenting cells.  ICAM-1  ex- 
pression is upregulated as a consequence of B  lymphocyte antigen receptor (BCR) signaling, 
thereby serving to render antigen-stimulated B cells more receptive to T cell-mediated costim- 
ulatory signals. We have investigated BCIk-induced expression of the Icam-1 gene in primary B 
cells and B  cell lines and have found it to be dependent on BCR-induced expression of the 
transcription factor EGR1.  lcam-1  transcription, induced by BCR cross-linking or bypassing 
the BCR with phorbol ester, is absent in a B cell line in which the EGRl-encoding gene (egr-I) 
is methylated and not expressed. A potential EGRl-binding site was located at -701  bp up- 
stream of the murine Icam-1 gene transcription start site and shown by electrophoretic mobility 
shift assay to bind to murine EGR1. Mutation of this site in the context of 1.1 kb of the Icam-1 
promoter significantly abrogated transcriptional induction by phorbol ester and anti-~ stimula- 
tion in primary B  cells. A  direct effect of EGR1  on the lcam-I  promoter is suggested by the 
ability of EGI~I  expressed from an SV40-driven expression vector to transactivate the wild- 
type Icam-1  promoter, whereas mutation of the EGR1  binding motif at  -701  bp markedly 
compromises this induction.  These data identify EGR1  as a signaling intermediate in BCR- 
stimulated B cell functional responses, specifically linking BCR signal transduction to induction 
of the  Icam-1  gene.  Furthermore, similar findings for BCR-induced  CD44  gene induction 
(Maltzman, J.S., J.A. Carman, andJ.G. Monroe. 1996.  Role of EGR1 in regulation ofstimu- 
his-dependent CD44  transcription  in B  lymphocytes. Mol,  Cell.  Biol.  In  press)  suggest  that 
EGR1 may be an important signaling molecule for regulating levels of migration and adhesion 
molecules during humoral immune responses. 
A 
ntigen-specific activation of B  lymphocytes is a com- 
plex process initiated by signals generated through the 
B cell antigen receptor (BCR) 1. BCR signaling involves a 
series  of increasingly well-defined biochemical events re- 
sulting  in  alterations  of gene  expression  and  subsequent 
changes in the phenotypic and activation state of the B cell 
(1).  Although necessary to initiate the B  cell  response, in 
most cases BCR-generated signals are insufficient to drive 
later activation events such as proliferation and differentia- 
tion into antibody-secreting cells (2). For these later events, 
antigen-stimulated  B  cells  require  contact-dependent sig- 
nals delivered by T  cells.  These contact-dependent second 
signals involve ligand-receptor interactions between mole- 
cules expressed on the antigen-stimulated T and B cells (2). 
1Abbreviations used in  this paper: BCR, B cell antigen receptor; CAT 
chloramphenicol acetyl  transferase; EMSA, electrophoretic  mobility  shift 
assay; GAPDH, glyceraldehyde-3-phosphate  dehydrogenase; ICAM-1, 
lntracellular adhesion molecule 1; PAP, placental alkaline phosphatase. 
Molecules on the B cell that may be involved in costimula- 
tion with BCR signals include CD40 and MHC class II an- 
tigens,  which interact with  T  cell surface proteins  CD40 
ligand  (gp39)  and  TCR/CD4,  respectively (3,  4).  Addi- 
tional  paired  proteins  on  the  antigen-activated B  and  T 
cells function primarily to stabilize  the physical interaction 
between these cells. These adhesion molecules may initiate 
some costimulatory function as  well  (5,  6).  One of these 
cell adhesion molecules is intercellular adhesion molecule 
(ICAM)  1/CD54. 
ICAM-1 is the prototypic member of a family of hgands 
for  the  [3-2 integrin  LFA-1.  This  family  also  includes 
ICAM-2  and  ICAM-3,  although  ICAM-I  is  thought  to 
play the predominant role in B  cell-T cell interactions (7, 
8). Besides mediating interactions between B  and T  cells, 
ICAM-1-LFA-1  interactions have also  been implicated in 
B  lymphocyte  homotypic  adhesion  (9).  Expression  of 
ICAM-1  on B lymphocytes is upregulated by stimulation. 
For example, stimulation ofB lymphocytes by BCR cross- 
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(11,  12).  In endothelial  cells,  induced increase in ICAM-1 
expression is the result of elevated transcription of the Icarn-I 
gene (13,  14). 
Although transcriptional induction of the Icam-I gene by 
BCR  cross-linking can be inferred from other studies  (11, 
12),  the molecular processes involved in linking this gene 
to antigen receptor-initiated signaling events have not been 
analyzed, nor have the transcriptional  control elements for 
Icam-t in B ceils been studied. Analysis of the human Icam-I 
promoter revealed a  number of potential  binding sites  for 
inducible and constitutively expressed transcription factors, 
including NF-KB, SP1, and EGR1.  In this study, we pro- 
vide evidence that a B  cell line that lacks EGR1 expression 
is also compromised in its abi/ity to upregnlate Icam-I gene 
expression,  suggesting  a  role  for  the  transcription  factor 
EGR1 in BCR-induced Icam- 1 expression. 
EGR1  (NGFI-A [15], Krox-24  [16], z/f268  [171,  TIS8 
[18]) is encoded by an immediate-early response gene and 
is induced rapidly and transiently (within 30 rain and max- 
imaily by 2  h)  in response  to BCR  cross-linking or treat- 
ment with phorbol esters  (19).  Protein expression is maxi- 
mal  by  4  h  after  PMA  or  anti-p~  stimulation  (19).  By 
comparison, phorbol ester- and BCR-dependent increases 
in  ICAM-1  protein  expression  are  delayed,  detectable  by 
FACS  |  analysis  by 6  h  after  stimulation  (12).  EGR1  has 
been shown to be a  transcriptional  activator both in lym- 
phocytes  (20)  and  other  cell  types  (21,  22).  A  growing 
number  of EGRl-regnlated  genes in fibroblasts,  neurons, 
and kidney have been described (23-26).  Interestingly,  al- 
though egr-I expression is a common component of  the in- 
ducible  immediate-early  gene  response  in  nearly  all  cells 
studied,  the  majority of the  EGRl-regulated  genes so far 
identified have been tissue specific or restricted (27, 28). 
Based on the association of EGR1  with BCR  activation 
(i9),  its transcriptional  regulatory activity (20--22),  the  ki- 
netics of its  expression relative to Icam-1,  and our prelimi- 
nary  studies  in  EGRl-expressing  and  -nonexpressing  B 
cells, we considered EGR1 as a possible regulator of 1cam-I 
induction  after  BCR  cross-linking.  This  hypothesis  was 
tested in these studies. 
Materials and Methods 
Isolation of Murine B Lymphocytes, Cell Culture, and Flow Cytom- 
etry.  The WEHI-231 B cell lymphoma (American Type Culture 
Collection,  RockviUe,  MD)  and all  limiting dilution  subclones 
including WEHI-231.7 and WEHI-231.1F1 were maintained in 
DME, high glucose  supplemented with 10% FCS (Hyclone, de- 
fined;  Hyclone Laboratories  Inc., Logan, UT), SerExtend (Hana 
Biologicals,  Berkeley,  CA),  2  mM  t-glutamine,  nonessential 
amino acids (GIBCO/BRL, Gaithersburg,  ME)), and 5 X  10 -s M 
2-ME. Cells were maintained at a minimum and maximum den- 
sity of 104 and 5 X  10S/m1, respectively. 
B lymphocytes were isolated from spleens of BALB/c mice as 
previously described  (29). Briefly,  spleens were ground between 
the frosted ends of two glass slides to produce single cell suspen- 
sions.  After depletion  of T  cells by treatment with anti-Thyl.2 
antibody and complement and red blood cells by lysis with Gey's 
solution,  the  remaining  cell  suspension  was  centrifuged over a 
75% Percoll cushion, and the interface  was collected.  This treat- 
ment results  in a population of >90%  IgM+B220  + cells. Cells 
were then incubated at 37~  5% COz, for 72 h in B cell assay 
media  (RPMI  1640  supplemented  with  10%  FCS,  2  mM 
t-glutamine, nonessential  amino acids, 100 Ixg/ml penicillin,  100 
I.cg/ml streptomycin, and 5  X  10 -5 2-ME)  and 50 /Lg/ml LPS 
(Sigma Chemical Co., St. Louis, MO). 
Flow cytometric analysis was carried  out exactly  as described 
(30) using FITC anti-mouse I~ F(ab')2 (PharMingen, San Diego, 
CA) on a FACScan flow cytometer with LYSIS II software  (Bec- 
ton Dickinson & Co., Mountain View, CA). 
Plasmids and Constructs.  pBluelCAM containing the flail-length 
ICAM-1 cDNA in the EcoRI site of pBluescript  SK* (Stratagene 
Inc., La JoUa, CA) was provided by Dr. A. Brian (La Jolla Cancer 
Research  Foundation,  La Jolla,  CA).  pGAPDH  contains  the 
full-length  murine  glyceraldehyde-3-phosphate  dehydrogenase 
(GAPDH) cDNA and was provided by Dr. M.  Prystowsky (Al- 
bert Einstein  School of Medicine, Bronx, NY). The plasmid con- 
taining the  murine  c-myc  cDNA was  obtained from American 
Type Culture Collection. The empty expression  vector pBX and 
pBXEGR1  containing the  full-length EGR1  cDNA driven by 
the SV40 promoter have been described (20). pSV2PAP, contain- 
ing the gene for placental alkaline phosphatase  (PAP), was kindly 
provided by Dr. T. Kadesch (University of Pennsylvania). 
pBLICAM and  pBLmlCAM  contain  1.1  kb  of the  murine 
ICAM-1 5' flanking region including its transcription  start site. A 
1.t-kb BsiHKAI fragment spanning -1091  to +34 was excised 
from El0 (31), blunt ended with T4 polymerase,  and cloned into 
the  PstI site  of the  promoterless  chloramphenicol acetyl trans- 
ferase  (CAT)  vector  pBLCAT2.3  (32).  For  construction  of 
pBLmlCAM, splicing overlap  PCR (33) was used to mutate the 
EGRl-binding  site  located  at  -701  bp.  The  oligonucleotides 
used were 5'-GAGGCATATGGGCGGGAGC-3' and 5'-CCG- 
CCCATATGCCTCGGTTCC-3'. Presence of the mutation was 
confirmed by sequencing using a Sequenase  2.0 kit (USB, Cleve- 
land, OH) according to the manufacturer's instructions. 
RNA Isolation and Northern Blot Analysis.  Cells were brought 
to a concentration of 5 ￿  10S/ml in fresh 37~  media and then 
equilibrated  for I-2 h at 37~  5% CO2. A~er preincubation,  10 
ng/ml PMA,  10  ~g/ml goat anti-mouse tz  F(ab')2  (Chemicon 
International  Inc.,  Temecula,  CA),  or  50  I~g/ml  rabbit  anti- 
mouse IgM F(ab')2 was added as indicated in the text,  and total 
RNA was isolated  using the acid guanidinium thiocyanate-phe- 
nol-chloroform method (34). Equal amounts of RNA were elec- 
trophoresed on a 12% formaldehyde-agarose gel and blotted to 
nylon  membranes  (GeneScreen  Plus;  DuPont/NEN,  Boston, 
MA), fixed by UV irradiation,  and baked for 2 h at 80~  in a vac- 
uum  oven.  cDNA probes were  labeled  using incorporation of 
[32p}dCTP by nick translation  (GIBCO BILL) according to the 
manufacturers instructions.  At~er a  I-6 h prehybridization in 50 
mM  Pipes  (pH  6.8),  50  mM  NaPO4,  100  mM  NaCI,  1  mM 
EDTA, and 5% SDS  at  65~  denatured probe was added,  and 
hybridization was  carried out for 12-16 h  at  65~  Blots  were 
washed at 65~  for 3 X 20 rain with 1 ￿  SSC and 5% SDS, 3 ￿ 
20 rain with 0.5)<  SSC and 0.1%  SDS,  and 3  ￿  20 rain with 
0.2)<  SSC and 0.1% SDS.  Quantitative analysis was carried  out 
using  a  Phosphorlmager  and  lmageQuant  software  (Molecular 
Dynamics, Sunnyvale, CA). 
Nuclear Run-On Transcription Assays. Exponentially  growing cells 
were  aliquotted  into  50-rrd  conical  tubes  and  equilibrated  at 
37~  5% CO2 for 2 h and stimulated  with 10 ng/ml PMA. At 
the indicated times, cells were pelleted,  washed twice with PBS at 
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mM MgC12, 1.0 mM dithiothreitol, 2 mM PMSF, and 1.5 Ixg/ml 
each  of pepstatin A, chymotrypsin, leupeptin, and antipain) on 
ice for 15 min. After one wash in lysis buffer, nuclei were resus- 
pended in 1 ml oflysis buffer with 10 I~g/ml RNase A for 30 min 
at 4~  to remove cytoplasmic RNA. Nuclei were then washed 
twice in lysis buffer at 4~  and resnspended at 107 nuclei/100 IxL 
in NSB (50% glycerol, 0.02 M  Tris-Cl, pH 7.9, 0.075 M  NaCI, 
0.5  mM  EDTA,  0.85  mM  dithiothreitol,  0.125  mM  PMSF), 
placed into a dry ice/EtOH bath for 20 min and stored at -70~ 
Run-on transcription was carried out at 26~  for 10 min in a 
200-txL  volume  with  reaction  buffer  (29%  glycerol,  100  mM 
Tris-C1, pH 7.9, 50 mM NaC1,  4.0 mM MnC12, 1.2 mM dithio- 
threitol,  0.1  mM  PMSF,  0.4  mM  EDTA,  1.0  mM  nucleoside 
triphosphates, 10 mM phosphocreatine, 40 U  RNAsin (Promega 
Corp., Madison, WI), 2.5 I.zM UTP, and 200/,~Ci [32p]UTP)  fol- 
lowed  by  addition  of  1.5  U  RNase-free  DNase  (Boehringer 
Mannheim Corp., Indianapolis, IN) and incubation at 26~  for 
an additional 5 rain. Reactions were terminated by addition of 1 
rrd  of guanidinium  thiocyanate-phenol-NaOAc,  pH  4.0,  and 
RNA  was  extracted as  described  (35).  Unincorporated  nude- 
otides were removed by two successive NH4OAc (2.5 M)/EtOH 
precipitations. Prehybridized Genescreen  Plus  membranes  (Du- 
Pont/NEN,  Boston, MA) containing 5 lxg of denatured pBlue- 
script SK  +  with  or without  inserts containing murine  ICAM1 
(pBIuelCAM) or murine GAPDH (pGAPDH) were hybridized 
for 65 h at 42~  with 1.2  ￿  107 cpm of nuclear run-on products 
in  I  ml of 50%  forrnamide, 5￿  SSC, 50 mM NaPO4,  pH 7.0, 
0.1% NaPPi,  1% SDS, 1 mg/ml heparin, and 100 Ixg/ml sheared 
herring sperm DNA.  Membranes  were  washed  for  15  min  at 
22~  (2￿  SSC, 0.1% SDS) and  15 min at 68~  (0.1￿  SSC,  1% 
SDS). Quantitative analysis was performed as described above. 
Electrophoretic Mobility Shift Assays.  Exponentially growing cells 
were stimulated with  10 ng/ml PMA for 2  h,  washed twice in 
PBS at 4~  and nuclear extracts were prepared as described else- 
where (36, 37).  The probe containing the BsaHI/DdeI fragment 
spanning -657 through  -747 bp was labeled using T4 polynu- 
cleotide kinase according to the manufacturer's instructions (New 
England Biolabs, Inc., Beverly, MA) and purified on a 9% native 
polyacrylamide gel. Binding reactions were carried out in a 20-1xl 
volume  containing  10,000  dpm  labeled probe,  nuclear extract 
containing  10  ~g  of protein,  1  ~g  poly  (dI-dC)-poly(dl-dC) 
(Pharmacia Biotech Inc., Piscataway, NJ),  10 mM Tris, pH 7.5, 
40 mM NaC1,  1 mM EDTA, 1 mM 2-ME and 4% glycerol with 
or without competing oligonucleotides as indicated in the text. 
For antibody-blocking experiments,  antisera specific for  either 
EGR1  or CDK4  (Santa  Cruz Biotechnology, Santa Cruz,  CA) 
were  preincubated  with  nuclear  extract  and  poly  (dI-dC)- 
poly(dI-dC) for  15  rain at room temperature. After addition of 
reaction buffer and labeled probe,  the reaction was  allowed to 
proceed for an additional 15 rain at room temperature. Reactions 
were loaded onto  a  4%  polyacrylamide gel in  0.5￿  TBE  (1￿ 
TBE is 100 rnM Tris base, 89 mM boric acid, 2 mM EDTA) and 
electrophoresed at 120 V at room temperature. 
Double-stranded oligonucleotides containing consensus bind- 
ing sites for AP1  (5' CGCTTGATGAGTCAGCCGGA 3') and 
SP1  (5'  ATTCGATCGGGGCGGGGCGAGC  3')  (Promega 
Corp.), as well as consensus EGR1 (5' GGATCCAGCGGGGGC- 
GAGCGGGGGCGA 3') and mutant EGR1 (5' GGATCCAGC- 
TAGGGCGAGCTAGGGCGA 3'), the latter of which fails to 
bind to murine and human EGR1,  were purchased from Santa 
Cruz Biotechnology. 
Tram'lent Transfections, CA T Assays, and PAP Assays.  For tran- 
sient transfections of WEHI-231, cells were grown to 4-5 X  105 
cells/ml in media supplemented with  100  U/ml  penicillin and 
100 Izg streptomycin (supplemented WEHI-231 media). 107 cells 
were washed once in STBS (25  mM Tris-Cl, pH 7.4,  137  mM 
NaC1,  5 mM KCI. 0.6 rnM Na2HPO4,  0.7 mM CaC12. and 0.5 
mM MgCI2)  and resuspended in 1.5 ml of 1X STBS, 0.5 mg/ml 
DEAE--dextran (Pharmacia Biotech Inc.), and the indicated plas- 
mid DNA. After a 30 min incubation at room temperature, cells 
were washed once in STBS and resuspended at 2.5  ￿  105 cells/ 
ml in fresh supplemented WEHI-231  media. Cultures were di- 
vided and stimulated 28 hafer transfection. After a 14-h stimula- 
tion, cells were harvested and assayed for CAT as described (32). 
To  control for  transfection efficiency, cells  were  cotransfected 
with pSV2APAP expressing alkaline phosphatase, and enzymatic 
activity was determined as described (38). 
Primary lymphocytes were transfected as described (29). Briefly, 
2.5  ￿  107 LPS-blasted cells were washed once in STBS and re- 
suspended at 107 cells/ml in STBS containing 500 ~g/rnl DEAE- 
dextran and the indicated plasmid DNA for 30 min at 37~  Cells 
were  then  washed  once  in  STBS  and resuspended at 5  ￿  106 
cells/ml in fresh B  cell assay media and incubated at 37~  5% 
CO2. After 24 h, cells were split into two equal groups and either 
left unstimulated or stimulated with  10  ng/ml  of PMA.  Atier 
an additional 24-h incubation, cells were  harvested and assayed 
for CAT. 
Results 
Differential  Expression  of EGR1  in  Subclones  of  WEHI- 
23 I.  We have previously reported a clone of the WEHI- 
231  B  cell Line  (WEHI-231.7)  that  does not  express egr-I 
upon anti-it or phorbol ester stimulation (35).  Lack of in- 
ducible expression of egr-1 was shown  to be due  to gene- 
specific DNA  methylation in these cells (39).  Immunocy- 
tochemical  analysis  of the  parental  WEHI-231  cell  Line 
from which WEHI-231.7 was cloned demonstrated cell-to- 
cell heterogeneity with  respect to egr-1  expression  (Mon- 
roe, J.G.,  unpubLished  observations).  Therefore,  a  subse- 
quent  WEHI-231  clone  was  derived  (WEHI-231.1F1)  in 
which egr-I was expressed at both the message and protein 
levels after anti-it or phorbol ester stimulation. 
As shown in Fig. 1, cross-Linking of the BCR. with anti-it 
antibodies or stimulation with  the phorbol ester PMA re- 
sulted in a rapid induction of egr-1 mRNA in WEHI-231.1F 1 
cells.  In contrast,  neither stimulus  was  able to induce  de- 
tectable  egr-1 mRNA  in  WEHI-231.7  cells.  Differential 
expression cannot be attributed to different kinetics of in- 
duction because no detectable egr-1 mR.NA in the WEHI- 
231.7 cells is observed at any time between 0.5 and  12 h  of 
stimulation with anti-it or PMA (35, 39). It is important to 
note here that as far as we have been able to ascertain, the 
observed difference in  BC1L-  and  PMA-induced egr-1 in 
these fines relates to gene-specific transcriptional silencing 
(39)  and  is not  associated with  quantitative  differences in 
BCR. expression or signaling. Both Lines exhibit compara- 
ble sIgM expression levels (Fig. 2  A) and undergo anti-it- 
and PMA-induced growth arrest (Maltzman, J.S., andJ.G. 
Monroe,  unpublished  data).  Furthermore,  the  difference 
seen in egr-I message is not representative of a generalized 
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sion of egr-  t.  WEHI-231.7 or WEHI-23  l. 1  F  1 were either left unstimu- 
lated (lanes 1 and 4) or were stimulated for 1 h with  either  10 ng/ml 
PMA or 50 Ixg/ml rabbit anti-mouse p. F(ab')2. Total cellular RNA was 
size fractionated by electrophoresis through  1.2% agarose-formaldehyde 
gel, transferred to GeneScreen Plus membranes, and hybridized simulta- 
neously with 32p-labeled  probes for egr-I and GAPDH  as described in 
Materials and Methods. 
inability to  induce  immediate-early gene  expression, since 
the  expression  of other  transcription  factors  encoded  by 
immediate-early genes such as c-myc  (Fig. 2  /3)  and egr-2/ 
krox-20  (data  not  shown)  does  not  differ between  these 
two lines. Thus, although we are unable to formally exclude 
the  possibility  that  WEHI-231.7  and  WEHI-231.1F17 
(hereafter referred  to  as  231.7  and  1F1,  respectively) may 
differ in parameters other than egr- 1 inducibility, this pair of 
related and otherwise phenotypically similar ceils affords us 
the  opportunity  to  identify  genes  whose  transcription  is 
regulated directly or indirectly by EGR1. We reasoned that 
BCR-induced  genes  that  require  EGRI  expression  for 
Figure 2.  Relative expression of surface IgM and inducible c-myc in 
WEHI-231.7  and WEHI-231.1FI. (,4) Surface IgM levels were  com- 
pared by flow cytometric analysis  of WEHI-231.7 (open  area) and WEHI- 
231.1F1 (shaded  area) for relative levels  of surface IgM expression. (/3) The 
inducible expression of c-myc was analyzed by Not'them  blot analysis. 
WEHI-231.7  or WEHI-231.1FI  were either left unstimulated or were 
stimulated for the  indicated times with  10 ng/ml PMA. Total  cellular 
RNA was subjected to  Northern  blot analysis and probed sequentially 
with -~-'P-labeled  cDNA probes for c-myc (top) and GAPDH (bottom). 
their  induction  would  show  similar differential induction 
patterns in 1F1 and 231.7 B  cells. 
Induction of Icam-1  Gene Expression  is Associated with EGR 1 
Expression in  IF1 and 23 I. 7 Cells.  For the reasons discussed 
previously, we considered Icam-1  to be a potential target of 
regulation by EGR1.  Consistent with this possibility, anti-I* 
stimulation of the EGRl-nonexpressing line (231.7)  failed 
to  induce  increased lcam-1  mRNA  expression  (Fig.  3  A). 
Failure to  induce  expression of Icam-1  mRNA  contrasted 
with  the  response  observed in  the  EGRl-expressing sub- 
clone  1F1,  in  which  we  observed  induction  of  Icam-I 
mRNA  by 2  h  after stimulation with anti-l*. Induction by 
anti-l* was  small (~2-fold at  2  h),  but this induction was 
significantly different  (P  <0.01)  than  that  seen  in  231.7 
cells across four independent experiments  (Fig. 3  A,  right). 
Bypassing the BCR by stimulating the cells with PMA also 
resulted in Icam-1  induction in 1F1  but not the egr-/-non- 
expressing line  231.7  (Fig.  3  B).  The  results of this  latter 
experiment were quantitated and are presented in Fig. 3  C. 
As with anti-I* stimulation, significant differences in Icam- I 
inducibility were  observed in  231.7  and  1F1  cells; in  this 
case,  PMA  induced  a  16-fold  increase  in  Icam-I  mRNA 
expression. Differential induction between  231.7  and  1FI 
was consistent over five independent experiments. Greater 
induction of Icam- 1 mRNA  by PMA than by anti-l* stimu- 
lation  is  consistent  with  our  previous  observations  that 
PMA  is more  efficient than  anti-I* in  its ability to  induce 
egr- 1 expression (19; see Figs. 1 and 6). 
Differential  Induction  of lcam-1  Is  Due  to  a  Difference in  the 
Rate of Transcription  Initiation.  Regulation  of Icam- I  tran- 
scription by EGR1  would predict that,  minimally, a  com- 
ponent  of the  difference  seen  in  the  induced  steady state 
lcam-I  mRNA  levels would  be  due  to  differences in  the 
rate of transcriptional initiation of the lcam-1  gene. To de- 
termine  differential  induction  of  Icam-I  transcription  in 
stimulated 231.7  and  1F1  B  cells,  we  carried  out  nuclear 
run-on analyses. Nuclei from 231.7  and 1F1  cells were iso- 
lated at various times after stimulation with PMA. The re- 
sults for  1F1  cells are shown  in Fig. 4  A. The rate of tran- 
scription initiation of Icam-1  was  increased at  1  h  (relative 
to unstimulated controls) after stimulation of 1F 1 ceils. The 
rate  of transcription  began  to  decrease  by  2  h  and  was 
down to basal levels by the 3-h time point, consistent with 
the kinetics observed by Northern blot analysis (Fig. 3). To 
quantitatively  compare  the  induction  of Icam-1  transcrip- 
tion between  1F1  and  231.7,  identical analyses were  per- 
formed using 231.7 nuclei, and band intensities were quan- 
tified  and  normalized  to  levels  of  transcription  of  the 
housekeeping gene encoding GAPDH. The results of these 
analyses are expressed graphically in Fig. 4  B. As indicated, 
stimulation of 1F1  cells led to a sevenfold increase in tran- 
scription at 1 h  compared with a threefold increase in 231.7 
cells.  These  results  indicate  that  the  differential levels  of 
induction  seen  at  the  steady state  level by  Northern  blot 
analysis are due at least in part to differences in the rate of 
Icam-1  transcription,  consistent  with  EGRl-dependent 
regulation. It is not obvious how differences in the level of 
inducibility as measured by Northern blot analysis (Fig. 3  B; 
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in  anti-Ix- and PMA-stimulated 231.7 and  1F1 
cells. 231.7 and 1F1 cells were either left unstimu- 
lated or  were stimulated with (.4) 10  p.g/rnl of 
F(ab')2 fragments of goat anti-mouse ~ antibodies 
(left and right) or (/3) 10 ng/ml PMA for the times 
indicated. Total RNA  was  size fractionated on 
1.2% agarose-formaldehyde  gels, transferred to Ge- 
neScreen Plus membranes,  and sequentially  hybrid- 
ized with 32p labeled cDNA probes for lcam-I  (.,t 
and B,  top) and GAPDH (.4 and B,  bottom). The 
right panel of A depicts the means  of four indepen- 
dent experiments  presented  as the mean fold induc- 
tion relative to unstimulated cells -+ SEM (loam-l 
mRNA expression levels were first normalized to 
GAPDH levels). (C) Quantitative  analysis  of PMA- 
stimulated loam-I and GAPDH P,.NA levels from B 
was  performed using a  Phosphorimager as  de- 
scribed in Materials and Methods. For each time 
point, the level of Icam-1 was normalized to the 
level of GAPDH. Fold induction is the normalized 
level of lcam-l  message at the time indicated di- 
vided by the normalized  level  ofunsrmulated lcam-1. 
16-fold)  and transcription initiation are  to  be  reconciled. 
Often,  the  levels  measured  by  these  two  assays  are  not 
identical;  run-ons  routinely  show  less  induction  than 
Northern blot analysis. This difference may reflect charac- 
teristics of the  assay  systems themselves, that  is,  efficiency 
and sensitivity or,  in some cases,  suggest a degree of post- 
transcriptional regulation in the induced cells. The critical 
point  in  this  analysis,  however,  is  the  clear  evidence  of 
transcriptional induction of lcam-I  in 1F1 and the elevated 
induction in  1F1  cells  compared  with  that  observed  in 
231.7 B  cells. 
EGR1  Binds to a Consensus Motif at  -701  bp qf the Murine 
lcam-1  Promoter.  Sequence analysis of the  human Icam-1 
promoter suggested two potential EGRl-binding motifs at 
-693  bp and -699  bp. At the onset of these studies, the 
sequence of the murine promoter had not been extended 
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beyond -660  bp  (31),  and therefore  could not be evalu- 
ated for the presence of these potential regulatory motifs. 
Further sequencing of the murine 5' region and analysis of 
the region between -660 and -1091 bp identified a single 
consensus EGRl-binding motif at -701 bp, an AP2 motif 
at  -883  bp, an NF-~13 motif at  -870  bp, and two  SP1- 
binding motif~ at -700 and -955 bp (shown schematically 
in Fig. 5 A). 
To determine if murine EGR 1 protein binds to the mo- 
tif at  -701  bp,  nuclear extracts  isolated from  stimulated 
1F1  cells were used as a source of cellular EGR1 protein in 
electrophoretic mobility shift assays (EMSAs). Competition 
EMSA analysis was carried out using a radiolabeled 90-bp 
probe spanning the region from  -747  to  -657  bp (Fig. 5 
A). Addition of nuclear extracts from stimulated 1F1  cells 
resulted in multiple shifted complexes  (Fig.  5  B,  lane  1). Figure  4.  Differential induction of lcam-1 transcription initiation in 
231.7 and 1F1 cells, (A) Nuclei were isolated from 1F1 cells that had been 
stimulated with 10 ng/ml PMA for 0, 1, 2, 3, or 4 h and used as templates 
to produce 32p labeled nuclear run-on transcription probes as described in 
Materials and Methods. 5 I~g each of pBluescript SK  + vectors containing 
either loam-  I, GAPDH, or no insert were immobilized onto GeneScreen 
Plus membranes. The run-on transcription products were hybridized to 
the membranes. (B) Quantitative analysis of  PMA-stimulated loam-t tran- 
scription in 231.7 and 1F1 cells was performed using a Phosphorlmager. 
lcam-1 band intensities from the hybridized filters from A and a simulta- 
neous experiment using nuclei from PMA-stimulated 231.7 cells were 
quantitated and normalized to GAPDH intensities at  each time point. 
The results are expressed as fold induction versus unstimulated levels. 
Competition  with  oligonucleotides  containing  two  con- 
sensus  EGRl-binding  motifs  (ERE),  but  not  mutated 
EGR1 binding motifs (mERE), resulted in dose-dependent 
competition of a single intermediate-sized  complex (Fig,  5 
B, compare lanes 2 and 3 with  1 and 4). 
The potential EGRl-binding  site  at  -701  bp  is associ- 
ated  with  an  overlapping  SP1  site.  Therefore,  the  slower 
mobility  complex present  in  the  lanes  containing  extracts 
from either  231.7  or  1F1  cells  was  considered  to be  SP1, 
This  conclusion was  confirmed by experiments  shown  in 
Fig.  5  B in which ohgonucleotides containing a consensus 
SPl-binding  motif  specifically  competed  for  the  slower 
complex mobility (Fig. 5  B, compare lanes  1 and 5).  Con- 
versely, oligonucleotides containing an APl-binding motif 
did  not  compete  for  binding  of any  of these  complexes 
(Fig. 5 B, compare lanes  I and 6),  confirming the sequence 
specificity of these complexes. 
To  confirm  that  the  complex  competed  by  unlabeled 
EGR1  oligonucleotides contained EGR1  and not a related 
family member, two types of experiments were performed. 
First,  addition  of rabbit  antiserum  specific  for a  COOH- 
terminal  region  of the  EGR1  that  is  not shared  by other 
EGR family members  (40-43)  resulted in a specific super- 
shift of the intermediate  mobility complex that was previ- 
ously  shown  to  be  disrupted  by  competition  with  unla- 
beled  EGR1-  but  not  SPl-binding  sites  (Fig.  5  C).  In 
contrast,  a  control  rabbit  antiserum  did  not  supershift  or 
disrupt  the  complex.  In a  second type of experiment,  nu- 
clear extracts  from stimulated  and unstimulated  231.7  and 
1F1  cells were compared (Fig.  5  D).  If the protein partici- 
paring in formation of the intermediate mobility complex is 
EGR1, then this complex would be expected to be unique 
to  1F1  nuclei  (compared  with  231.7)  and  also  should  be 
more abundant in stimulated extracts.  In comparison, since 
SP1 is a ubiquitously expressed transcription factor (44), its 
binding activity should be  observed in both subclones.  As 
shown  in  Fig.  5  D,  the  EGR1  complex is  unique  to  the 
1F1  cells,  and its abundance increases with stimulation.  In 
addition,  the  slow  mobility  complex  identified  as  SP1  by 
competition  experiments  is  present  in  both  cell  lines  re- 
gardless of stimulation  (Fig. 5 D).  In contrast to EGRI, in- 
creased binding of SPl after stimulation of 1F1 cells is not a 
reproducible finding in our hands. 
Involvement of the  -701-bp  EGRl-binding  Site  in  Icam-1 
Induction.  The  above  studies  have  identified  a  potential 
EGRl-binding site in the 5'  lcam-1 promoter and demon- 
strated the  ability of this site  to bind  to EGR1.  To deter- 
mine  whether  this  site  is  important for the  transcriptional 
regulation  of Icam-1  in  anti-w-  and  PMA-stimulated  B 
lymphocytes, we mutated this site in the context of the en- 
tire Icam- 1 promoter. Reporters containing either 1.1 kb of 
the murine Icam-1 promoter (-1091-+34  bp) upstream of 
the  CAT reporter gene  (pBLICAM),  or a variant  derived 
by site-directed  mutagenesis  of the  EGRl-binding  site  at 
-701  bp  (pBLmlCAM)  were  constructed  (see  Fig.  7  A). 
The mutation within the pBLmlCAM construct consists of 
a  5-bp  substitution  that  abolishes  the  ability  of EGR1  to 
bind  to  the  -701-bp  site  but,  importantly,  retains  SPl- 
binding activity as determined by EMSA (data not shown). 
To test the effect of this mutation on the ability to induce 
lcam-I  gene  expression  in anti-I~- and PMA-stimulated  B 
cells,  we exploited the use of the LPS blast transfection sys- 
tem that we have  previously described  (29).  The  strength 
of this  is that it allows us to analyze inducibility in a non- 
transformed  primary B  cell;  caveats  associated  with  trans- 
formation  of  established  tissue  culture  lines  are  thus 
avoided.  Importantly, both  Icam-1  and  egr-1  are  inducible 
by PMA and anti-I~ in the LPS blast system (Fig. 6). 
B  lymphocytes, transiently  transfected with  either pBL- 
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-701 bp of the murine loam-1 promoter. (A) Sche- 
matic  representation  of the  distal murine  lcam-1 
promoter indicating the radiolabeled probe used for 
EMSA (hatched  bar). The probe spans from -657 to 
-747  bp.  The basepair sequence from  -697  to 
-713  bp  is  shown  to  indicate  the  overlapping 
EGR1  and Spl consensus-binding motifs and the 
immediately flanking sequences. Also shown sche- 
matically are potential binding motifi  for NF-kB 
(-870 bp), AP2 (-883 bp), and an additional SP1 
motif (-955  bp).  Gel mobility shift assays were 
performed using 5 ~g of nuclear extracts from 1F1 
cells stimulated for 2 h  with  10 ng/ml PMA and 
the 3~ labeled probe depicted in A. To identify the 
proteins  in  DNA-protein complexes, competing 
oligonudeotides  (B) or antisera (C) were preincu- 
hated with extract for 10 min at 4~  the probe was 
added, and binding was allowed to proceed for an 
additional 15 min at room temperature. Unlabeled 
oligonucleotide competitors were used at either 20- 
fold molar excess (EGR1 response element [ERE], 
low concentration) or 100-fold molar excess (re- 
maining competitions). The supershified complex 
in C with the anti-EGR1  antibody is indicated by 
the (o). (D) Nuclear extracts from either 231.7 or 
1F1 that were umtimulated or stimulated with 10 
ng/ml of PMA for 2 h  were incubated with  the 
probe as described in B. 
ICAM  or  pBLmlCAM,  were  left  unstimulated  or  were 
stimulated with anti-g. (Table 1) or PMA (Fig. 7 and Table 
1). The level of basal CAT activity from unstimulated cells 
was approximately equal whether the EGR1  motif was in- 
tact or mutated (Fig. 7  B). Marked induction (~25-fold) of 
lcam-1 promoter activity was observed after PMA stimula- 
tion of cells transfected with the wild-type construct. Iden- 
tical stimulation of the  cells transfected with  the  mutated 
promoter resulted in a 50-75% reduction in inducible pro- 
moter activity relative to induction of the wild-type con- 
struct.  Abrogation of transcription induction of the Icam-1 
promoter by mutation of the  -701-bp  EGRl-binding site 
was  observed in five separate experiments in which  PMA 
was  the  stimulus  (Table  1).  Importantly,  although  induc- 
tion  by  anti-g,  stimulation  is  less  than  that  observed  for 
PMA,  mutation  of the  defined EGRl-binding  site none- 
theless  abrogated induced levels of transcriptional activity 
by  48-68%  across  three  separate  experiments  (Table  1). 
From  these  studies,  we  can  conclude  that  the  -701-bp 
EGRl-binding  motif is required for  the  full induction  of 
the Icam-1  promoter. 
Exogenous EGR 1 Transactivates the Icam-1  Promoter.  The 
above results show  that the EGR1  motif (independent  of 
the overlapping SP1 motif) is necessary for full activation of 
the Icam- 1 promoter in anti-~- or PMA-stimulated B  cells. 
1753  Maltzman et al. 
Coupled with  the  studies  using  the  231.7  and  1F1  B  cell 
lines, these data provide strong correlative evidence for the 
importance  of  EGR1  in  BCR-inducible  expression  of 
Icam-1.  To  more  directly determine a  role  for the EGR1 
protein in  Icam-1  gene  regulation, we  tested the  ability of 
plasmid expressed EGR1  to  transactivate  the  Icam-1  pro- 
moter. For these studies, we used the 231.7 cells so that the 
experiments  would  not  be  complicated  by  endogenous 
EGR1  expression.  231.7  B  cells were  cotransfected with 
the  wild-type Icam-1  promoter/CAT  reporter gene  (pBL- 
ICAM)  and  varying amounts  of an  SV40-driven  murine 
EGR1  expression vector (pBXEGR1).  Transfections were 
performed  in  PMA-stimulated 231.7  B  cells,  maintaining 
equivalent  amounts  of expression vector DNA  (5  bLg) by 
inclusion  of appropriate  amounts  of the  empty  cassette, 
pBX.  As can be seen  (Fig.  8  B,  solid  bars), we  observed a 
dose-dependent increase in Icam- 1 promoter activity associ- 
ated with increasing amounts of EGR1  expression vector. 
In the above case, EGR1  could be acting directly or in- 
directly through  this promoter.  However,  we believe that 
this  effect  is  mediated by  direct  effects  of EGR1  on  the 
Icam-1 promoter because mutation of the -701-bp  EGR1- 
binding  site  completely  abrogates  the  EGRl-mediated 
transactivation (Fig. 8 B, hatched bars). Therefore, the trans- 
activation studies  clearly establish the  ability of EGR1  to Figure 6.  BCR cross-linking and PMA stimulation 
induce lcam-I and egr-1 mRNA in LPS blasts. Purified 
splenic B lymphocytes were stimulated for 72 h with 
50 p.g/ml of LPS. Cells were washed twice with PBS 
and cultured for an additional 24 h in the absence of 
LPS. Cells were then stimulated with either  10 ng/ml 
PMA (lanes 1-5) or 10 i~g/ml of F(ab')2 fragments of 
goat anti-mouse I~ (lanes 6-10) for the times indicated 
above each lane. Equivalent amounts of RNA were 
size fractionated,  transferred to  a  GeneScreen  Plus 
membrane,  and  hybridized  with  32p  labeled  cDNA 
probes for Icam-1 (A, top). The membrane was stripped 
and simultaneously  reprobed for egr-  1 and GAPDH (A, 
bottom). The relative locations of 28S and 18S rRNA 
are  indicated to  the  right.  (B)  The  levels of lcam-1 
mRNA expression were quantitated and normalized to 
GAPDH  expression. Values are presented as fold in- 
duction after PMA or anti-p, stimulation relative to un- 
stimulated cells. 
induce transcription via the Icam-1  promoter and,  further- 
more,  establish that  this  effect is most  likely to  be  direct. 
The  observation  that  mutation  of the  lcam-l-associated 
EGRl-binding site abolishes EGR1  transactivation of this 
promoter indicates that EGR1  is not acting indirectly via 
regulation of another transcription factor. 
Discussion 
Activation of B  lymphocytes  by  antigen  is  a  complex 
process that integrates membrane, cytoplasmic, and nuclear 
processes into long-term phenotypic and functional changes 
in  the  B  cell.  These  activation-associated events  regulate 
the  ability of the B  cell to  present processed antigen to  T 
cells, function as an immune effector cell, and generate an- 
tigen-specific  memory  cells.  Transcription  factors  whose 
expression  is  induced  after  BCR  signaling facilitate cou- 
pling  between  receptor-induced  second-messenger  path- 
ways and the nuclear events that regulate these phenotypic 
and functional changes.  Here we have investigated a single 
and defined event that is necessary for an antigen-induced 
immune response (45, 46). We have shown that induction 
of Icam-1  transcription after BCR-induced  signals is  cou- 
pled to the BCR  via the transcription factor EGR1. In our 
previous  studies,  we  identified  the  p21'~/~/MAP  kinase 
pathway as the  important signaling pathway linking BCR 
or phorbol ester stimulation to  egr-I  gene  induction  (47). 
Taken  together,  these  studies  define  a  role  for  the  p21 r~ 
pathway and EGR1  in linking BCR  cross-linking to  im- 
munologically  relevant  functional  responses  in  B  cells; 
namely,  the  upregulation  of expression of a  gene  directly 
involved in B  cell-T cell interaction.  Adhesion molecules 
such  as  ICAM-1  function  to  stabilize interactions with  T 
cells during the period in which the B  cells manifest a  re- 
quirement for secondary signals to further promote activa- 
tion and differentiation of the antigen-stimulated B  cell. 
The importance of EGR1  in the induction of Icarn-1  ex- 
pression after BCR  cross-linking is based on several lines of 
mutually  supporting  evidence:  (a)  we  have  demonstrated 
that  the  -701-bp  EGRl-binding  site is necessary for  the 
full inducible activity of the Icam-I  gene in response to ei- 
ther BCR  ligation or in situations in which the receptor is 
bypassed by stimulation with phorbol ester; (b) B  cell lines 
that differ in their ability to express EGR1  also show differ- 
ential inducibility of Icam- 1 gene expression; and (c) exoge- 
nous  EGR1  is  able to  transactivate  the  Icam-1  promoter, 
and mutation of the -  701-bp EGR 1-binding site abolishes 
this  transcriptional activation.  The  caveats and  interpreta- 
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Figure  7.  Mutation of the EGKl-binding site at  -701  bp abrogates 
inducible Icam-  I promoter activity. (A)  pBLICAM contains 1.1 kb of 5' 
flanking sequence from  the  murine lcam-1 gene  cloned  upstream of a 
CAT  reporter.  The  mutated construct (pBLmlCAM)  contains the de- 
picted  5-bp mutation.  (B)  After a  72-h pretreatment with LPS,  B  cells 
were  transfected with  10  I.tg of either  pBLICAM  (wild type)  or pBL- 
mICAM (mutant) and rested for 24 h. Cultures were then evenly divided, 
and cells were either stimulated with 10 ng/ml PMA (hatched bars) or leR 
unstimnlated (solid bars). Cells were harvested 24 h  later and assayed for 
CAT acuvity as described in Materials and Methods. Different prepara- 
tions of LPS and each plasmid gave similar results. 
Table  1.  Both PMA- and Anti-p.-stimulated Icam- 1 Gene 
Transcription  Is Abrogated  by Mutation of the EGR1-binding  Site at 
-701  bp 
Experiment 
Fold induction 
reporter  Stimulus  1  2  3  4  5 
Wild-type lcam-1  PMA  28.1  25.5  26.9  21.2  20.0 
Mutant (-701bp)  PMA  9.1  10.3  10.9  9.4  11.4 
Wild-type Icam- I  Anti-I~  1.7  2.5  5.1 
Mutant (-701  bp)  Anti-p,  0.7  0.8  2.7 
Experiments represent individual separate experiments using the wild- 
type and mutant lcam-1 promoter-CAT reporter constructs described 
in Fig. 7. Primary B cells (LPS blasts) were transfected with pBLICAM 
(wild-type) or pBLmlCAM (mutant -701  bp) and stimulated with ei- 
ther PMA (10 ng/ml) or anti-p, antibodies (50  gtg/rnl) as described in 
Fig. 7. Results are fold induction relative to umtimnlated control cultures. 
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tions of each of these conclusions will be discussed in detail 
below. 
Whereas mutation of the  -701-bp  EGRl-binding site 
abolishes as much as 75%  of the inducible  activity of the 
Icam-1 gene in B  cells,  it does not abolish all inducible ac- 
tivity,  suggesting  regulation  by  other  as  yet  unidentified 
transcription factors. Clearly, all Icam-1 expression in B cells 
is not dependent upon EGR1  expression. In 231.7 B cells, 
which do not express EGK1, as well as resting 1F1 and pri- 
mary B cells, significant levels of Icam-I mKNA expression 
are detectable despite the relative lack of measurable egr-1 
expression (see  Figs.  3  and 6).  We interpret these findings 
to indicate that whereas BCR-inducible Icam-1  expression 
is to a large extent dependent upon EGK1, basal or resting 
levels are  regulated  by another mechanism.  The  SP1  site 
A 
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Figure  8.  EGR1  is able to transactivate the lcam-I  promoter through 
the -701 bp site. Transient cotransfections were carried out using 231.7 
cells and 30 I.Lg  of plasmid DNA containing a mixture of 20 p~g lcam-I re- 
porter  plasmid  (pBLICAM  or  pBLmlCAM),  5  p.g  expression  vector 
(combination of pBXEGK1  plus the empty expression vector pBX), and 
5  I.tg pSV2PAP to control for transfection efficiency. The plasmids used 
are  illustrated in  A.  In  B,  the wild-type  reporter  construct pBLICAM 
(solid bars) or mutated pBLmICAM (hatched bars) were cotransfected with 
the indicated amount of pBXEGRA  and enough pBX to bring the total 
amount of expression vector DNA to 5  gtg. 32 h  after transfection, cells 
were stimulated with 10 ng/ml of PMA. Cells were harvested after 14 h 
of stimulation, and CAT and PAP activities were quantitated as described 
in Materials and Methods. The relative CAT activity is shown. may be important for this  regulation.  As  discussed  previ- 
ously, SP1  is a constitutively expressed transcription factor 
in these cells,  and, as shown in the EMSA experiments, it 
binds to the promoter in the unstimulated cells.  Its role in 
the inducible  expression of lcam-1 was not directly evalu- 
ated in these studies because the integrity of the SPl-bind- 
ing site was maintained in the mutations of the  -701-bp 
site.  The  fact that  inducible  activity was reduced  by 50- 
75% despite the ability of SP1  to still bind to this site indi- 
cates that it is not the major regulator of inducible  Icam-1 
expression.  However, it is still  possible that the inducible 
activity remaining when EGR1  binding  is  abolished may 
be due to the intact binding of SP1  to this site. Changes in 
the levels of SP1  or its posttranslational modification in re- 
sponse to BCR or PMA stimulation may contribute to the 
activity of the Icam-1  promoter under conditions in which 
EGR1 is absent or cannot bind. Alternatively, other sites in 
the promoter may also contribute to the inducible activity 
of this promoter after BCR or PMA stimulation.  For ex- 
ample, an NF-KB-binding motif has been implicated in cy- 
tokine-induced  Icam-1  expression  in  human  endothelial 
cells  (13,  48, 49). Regardless of the contributions of either 
of these  mechanisms to the  inducible  activity of the pro- 
moter in  the  absence  of EGR1  binding,  our data  clearly 
implicate EGR1 as the major regulator of Icam-1  transcrip- 
tion in BCR- and PMA-stimulated B cells. 
Before leaving this subject, it could be argued that it is a 
protein other than EGR1 that binds to the -701 motif and 
regulates the transcriptional activity of this promoter. Sev- 
eral lines  of evidence  argue  against  this  possibility,  how- 
ever. First and foremost is the observation that induction of 
Icam-I is compromised in the 231.7 cells that fail to express 
EGR1 but do not differ in their expression of the other egr 
family member (egr-2),  which can also bind this site (49a). 
Secondly,  the  EMSA  analysis  of  the  -701-bp  region 
shown in Fig. 5 identified a single band that was associated 
with the ability to induce Icam-1  expression (i.e., this band 
comigrated with  a  complex associated with the  -701-bp 
site  in  EGRl-expressing  but  not  -nonexpressing  B  cells 
and was specifically blocked with a consensus EGRl-bind- 
ing  site  but  not  a  mutated  one).  Most  importantly,  the 
complex associated  with  this  band  was  shown  to  be  dis- 
rupted  with  antibodies specific to the EGR1  protein.  Fi- 
nally,  the  transactivation  studies  establish  the  ability  of 
EGR1  to activate this promoter through this motif. In the 
231.7  EGR1  nonexpressors,  even  after  stimulation  with 
PMA, significant induction required exogenous EGR1 ex- 
pression. Taken together, these results indicate strong sup- 
port for our interpretation that EGR1  is the relevant tran- 
scription factor in this response. 
Because  231.7  B  cells  do  not express EGR1,  we were 
able to perform the transactivation studies using stimulated 
cells. By doing so, we were not only able to test the ability 
of EGR1  to transactivate this promoter, but also to estab- 
lish  the  importance of EGR1  under  conditions  in which 
any other putative induced transcriptional regulators would 
be  present.  The  observation  that  significant  Icam-1  pro- 
moter activity required  the  expression of EGR1  and  that 
this transactivation depended upon the ability of EGR1  to 
bind this promoter (i.e., mutation of the -701 site blocked 
this  response)  demonstrates three  things.  First,  EGR1  can 
activate this promoter.  Second,  the lack of Icam-1  induc- 
ibility in 231.7 is not due to a repressor of transcription, be- 
cause this putative repressor would be expected to inhibit 
transactivation  by  the  exogenous  EGR1  protein.  Third, 
significant  promoter  activity  requires  EGR1  even  under 
conditions in which other potential transactivators may be 
present. 
Interestingly,  in  light  of this  discussion,  when  similar 
studies  were  performed  in  unstimulated  231.7  cells,  we 
failed  to  observe  transactivation  of the  lcam-1  promoter. 
We  conclude,  therefore,  that  stimulation  is  necessary for 
transactivation  by  exogenous  EGRI  in  this  system.  Al- 
though this result does not negate the conclusion relevant 
to the studies here (i.e., that EGR1  does transactivate this 
promoter),  it  does  raise  some  interesting  possibilities  re- 
garding the mechanism of EGR1 transcriptional regulation. 
First  and  less  interesting,  the  requirement  for stimulation 
may reflect  the  need  to  stimulate  higher  levels  of trans- 
fected  EGR1  expression.  In  this  regard,  it  is  well-estab- 
lished that stimulation can increase the activity of the SV40 
enhancer. We do not believe that this is the case, however, 
because we observed similar effects using the 13-actin pro- 
moter, which is not affected by PMA or anti-Ix stimulation 
(data not shown). Also, as alluded to previously, stimulation 
may  induce  expression  of other  cofactors  that  cooperate 
with  EGR1  in  the  transcriptional  regulation  of this  pro- 
moter  (50-52).  Alternatively,  EGRI  may  require  post- 
translational  processing  provided  by  stimulation,  such  as 
phosphorylation,  to  exert its  activation effect (53-55).  In 
this  regard,  it is  interesting  that  the  major transactivation 
domain of EGR1 is rich in extended stretches of serine and 
threonine  residues  (20).  Phosphorylation of these  residues 
would be expected to impart a net negative charge to this 
region, and in so doing, possibly convert it from an inactive 
to active transcriptional activator. EGR1 is phosphorylated 
on serine residues in fibroblasts stimulated with serum (56), 
and this phosphorylation is associated with increased EGR1 
transcriptional  activity  (57,  58).  Evaluating  the  relative 
contribution of these effects is a current area of interest in 
our laboratory. 
Identification and use of the 231.7  and 1F1  B cells hnes 
is a significant accomplishment of these studies.  Their use 
in  these  studies  afforded  us  two  unique  advantages  over 
other  systems used  to  evaluate  transcription  factor-target 
gene relationships. First (as just discussed), they allowed us 
the opportunity to carry out transient cotransfection assays 
in stimulated  cells without  the  expression of endogenous 
EGR1. By comparing gene regulation in stimulated B cells 
with and without EGR1, we were able to evaluate the rel- 
ative importance of EGR1  expression in  the  presence  of 
other stimulation-associated processes. This level of analysis 
is not possible in the majority of model systems in which 
the  stimulus  would  induce  expression of the  endogenous 
transcription factor as well as these other potential events. 
Perhaps even more important, comparisons between 231.7 
1756  EGR1 Regulates Icam-1 Transcription and  1F1  have  allowed us to  evaluate Icam-1  regulation by 
EGR1  at  physiological levels  of EGR1  (endogenous  ex- 
pression  in  1F1)  and  with  the  Icam-1  gene  in  its normal 
chromosomal  context.  Whereas  transient  assay systems  as 
used in the majority of published studies allow for detailed 
deletion/mutation  mapping  of  promoter  elements,  the 
DNA  reporters  used  in  these  studies  lack the  constraints 
imposed by chromosome structure, which hmits the inter- 
pretation of studies relying fully on this type of experiment. 
The  231.7/1F1  system offers the  opportunity to  examine 
the  involvement  of EGP,,1  on  regulation  of endogenous 
genes.  The  combination  of transient  expression  data  and 
endogenous gene regulation makes this a unique system for 
studies of EGRl-regulated genes. Importantly, the cell line 
studies  are  further  strengthened  by  the  LPS  blast system, 
which has allowed us to confirm and extend these studies 
using a nontransformed B  cell model. 
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